Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of atrial fibrillation
3.2.1.2 Technological advancements in electrophysiology devices
3.2.1.3 Increasing preference for electrophysiology catheter ablation
3.2.2 Industry pitfalls and challenges
3.2.2.1 High investment for electrophysiology devices
3.2.2.2 Dearth of skilled professionals in emerging nations
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 EP ablation catheters
5.2.1 Radiofrequency (RF)
5.2.2 Cryoablation
5.2.3 Laser
5.2.4 Other EP ablation catheters
5.3 EP diagnostic catheters
5.3.1 Conventional
5.3.2 Advanced
5.3.3 Ultrasound
5.4 EP laboratory devices
5.4.1 Mapping systems
5.4.2 Recording systems
5.4.3 Other EP laboratory devices
Chapter 6 Market Estimates and Forecast, By Indication, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Atrial fibrillation
6.3 Ventricular tachycardia
6.4 Atrial tachycardia
6.5 Atrial flutter
6.6 WOLFF-Parkinson-white (WPW) syndrome
6.7 Atrioventricular nodal reentry tachycardia
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Catheterization/EP laboratories
7.4 Ambulatory surgery centers
7.5 Other end users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Russia
8.3.7 Ukraine
8.3.8 Poland
8.3.9 Switzerland
8.3.10 Belgium
8.3.11 Greece
8.3.12 Czech Republic
8.3.13 Netherlands
8.3.14 Sweden
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Malaysia
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Singapore
8.4.10 Taiwan
8.4.11 Philippines
8.4.12 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Kuwait
8.6.4 UAE
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 APN Health
9.3 Atricure
9.4 Biotronik
9.5 Boston Scientific Corporation
9.6 CardioFocus
9.7 GE Healthcare Technologies
9.8 Japan Lifeline
9.9 Johnson & Johnson
9.10 Koninklijke Philips
9.11 Medtronic
9.12 Microport Scientific Corporation
9.13 Merit Medical Systems
9.14 Siemens Healthineers
9.15 Stereotaxis
